InvestorsHub Logo
Followers 276
Posts 32697
Boards Moderated 0
Alias Born 11/14/2013

Re: dennisdave post# 692103

Thursday, 05/16/2024 3:32:13 PM

Thursday, May 16, 2024 3:32:13 PM

Post# of 700017
No, they are talking about therapies already approved elsewhere (like the U.S.) but were awaiting the standard first mhra assessment national review pathways.

The IRP national applicants left the standard national review and went to the IRP national review.

That reduced the queue in the national review assessment process DCVax-l is in.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News